TOxicity After Radiotherapy in breAst CancEr Survivors (ThORACeS) - A Retrospective Cohort Study
NCT02471079 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 706
Last updated 2024-02-28
Summary
Rationale:
The number of breast cancer (BC) patients at risk for long-term radiation-induced health problems is increasing, as their outcome is improving due to intensified treatment regimens, such as new systemic approaches and radiotherapy. Therefore, identifying BC survivors with the highest risk for radiation-induced health problems is crucial for developing strategies for primary and secondary prevention, which may contribute to healthy ageing.
Conditions
Interventions
- RADIATION
-
Radiotherapy
Sponsors & Collaborators
-
University Medical Center Groningen
lead OTHER
Eligibility
- Min Age
- 18 Years
- Sex
- FEMALE
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2014-09-30
- Primary Completion
- 2015-09-30
- Completion
- 2015-09-30
Countries
- Netherlands
Study Locations
More Related Trials
-
Exercise in Older Women With Breast Cancer During Systemic Therapy
NCT03656731 ·Status: COMPLETED ·Phase: NA
-
Treatment of Locally Advanced Breast Cancer With Letrozole in Postmenopausal Women
NCT00237133 ·Status: COMPLETED ·Phase: PHASE4
-
Hormone Replacement Therapy and the Risk of Breast Cancer Recurrence in Women With Previous Early Stage Breast Cancer
NCT00003771 ·Status: COMPLETED ·Phase: PHASE3
-
Study of Breast Cancer Prevention by Letrozole in High Risk Women
NCT00579826 ·Status: COMPLETED ·Phase: PHASE2
-
ExclUsive endocRine Therapy Or Radiation theraPy for Women Aged ≥70 Years Early Stage Breast Cancer
NCT04134598 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3
-
Antiestrogen vs Aromatase Inhibitor After Adjuvant Chemotherapy for Breast Cancer
NCT00437359 ·Status: TERMINATED ·Phase: PHASE2
-
Letrozole in Preventing Cancer in Postmenopausal Women Who Have Received 4-6 Years of Hormone Therapy for Hormone Receptor-Positive, Lymph Node-Positive, Early-Stage Breast Cancer
NCT00553410 ·Status: COMPLETED ·Phase: PHASE3
-
Pharmacology of Adjuvant Hormonotherapy in Breast Cancer
NCT01127295 ·Status: COMPLETED ·Phase: PHASE4
-
Letrozole as Early Adjuvant Treatment of Postmenopausal Patients With Primary Breast Cancer
NCT00332852 ·Status: COMPLETED ·Phase: PHASE3
-
OPTimizing Irradiation Through Molecular Assessment of Lymph Node (OPTIMAL)
NCT02335957 ·Status: COMPLETED ·Phase: NA
-
Letrozole or Tamoxifen in Treating Postmenopausal Women With Breast Cancer
NCT00004205 ·Status: COMPLETED ·Phase: PHASE3
-
An Integrated Consent Model Study to Compare Two Standard of Care Schedules for Monitoring Cardiac Function in Patients Receiving Trastuzumab for Early Stage Breast Cancer
NCT02696707 ·Status: COMPLETED ·Phase: PHASE4
-
Comparison Trial of Letrozole to Anastrozole in the Adjuvant Treatment of Postmenopausal Women With Hormone Receptor and Node Positive Breast Cancer
NCT00248170 ·Status: COMPLETED ·Phase: PHASE3
-
Neoadjuvant DPX-Survivac Aromatase Inhibition, Radiotherapy or Cyclophosphamide in HR+HER2- Breast Cancer
NCT04895761 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1
-
Low-dose Oral Cyclophosphamide and Methotrexate Maintenance for Hormone Receptor-negative Early Breast Cancer
NCT00022516 ·Status: COMPLETED ·Phase: PHASE3
-
TRial on the Endocrine Activity of Neoadjuvant Degarelix
NCT02005887 ·Status: COMPLETED ·Phase: PHASE2
-
Hormone Therapy and Chemotherapy in Treating Perimenopausal or Postmenopausal Women With Node-Positive Breast Cancer
NCT00002529 ·Status: COMPLETED ·Phase: PHASE3
-
A Study of Nonsteroidal Aromatase Inhibitors Plus Abemaciclib (LY2835219) in Postmenopausal Women With Breast Cancer
NCT02246621 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3
-
GEriatric Determinants of Curative RAdiotherapy Scheme Choice for Breast Cancer ELderly Patient Treatment Compliance and Tolerance
NCT02994914 ·Status: TERMINATED ·Phase: NA
-
Study of High-dose Letrozole Therapy in Postmenopausal Patients With Breast Cancer
NCT00237211 ·Status: COMPLETED ·Phase: PHASE2
-
Phase III Study of Atamestane Plus Toremifene Versus Letrozole in Advanced Breast Cancer
NCT00044291 ·Status: COMPLETED ·Phase: PHASE3
-
RAGE Inhibition to Decrease Cardiotoxicity in Women With Early Breast Cancer
NCT05256745 ·Status: RECRUITING ·Phase: PHASE1/PHASE2
-
Pre-Operative Window of Adjuvant Endocrine Therapy to Inform RT Decisions in Older Women With Early-Stage Breast Cancer
NCT04272801 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
Prospective Observational Study of Antitumor Activity Correlation Between Hormonal Therapy and Expression miRNA100
NCT02950207 ·Status: UNKNOWN
-
Study of the Efficacy and Safety of Letrozole Combined With Trastuzumab in Patients With Metastatic Breast Cancer
NCT00171847 ·Status: TERMINATED ·Phase: PHASE4